Fri 30 Oct 2026 International edition

Healthcare News & Policy Executive Overview: Unlocking the Early Mechanisms of Alzheimer’s Risk

Healthcare News & Policy Breakthrough in Sleep Science: The UT Austin NEUSLeeP Patch Targets Deep Brain Regions to Enhance REM Sleep Non-Invasively

Bio-Research & Life Sciences Unlocking the 518-Million-Year-Old Genesis of Spider Fangs: A Paleontological Breakthrough

Pathology & Histology Breakthrough in Computational Pathology: Introducing PRISM2, the First Clinical-Grade Multimodal Slide-Level Foundation Model

Bio-Research & Life Sciences Unlocking the Microscopic Archive: Advanced Genomic Analysis Reveals the Complex Biological Tapestry of the Shroud of Turin

Clinical Immunology The Gut Ecosystem Revolution: Why Intestinal Worms Need Dietary Fiber to Heal Us

Public Health & Epidemiology Bridging the Gap: How Community-Based Programs Shape the Mental Health, Resilience, and Settlement of Newcomer Youth

Healthcare News & Policy Revolutionizing Chair-Side Dentistry: UT Dallas Researchers Crack the Code for Rapid 3D-Printed Zirconia Restorations

Oncology & Cancer Research Breaking a 15-Year Microbiological Mystery: How a Common Gut Toxin Hijacks Colon Cells—and How Scientists Stopped It

Hematology & Blood Research Rethinking High-Risk Acute Promyelocytic Leukemia: A Landmark Meta-Analysis Challenges Decades of Intensive Chemotherapy Dogma

Molecular Biology & Genomics Unlocking Earth’s Deep History: The Quest for the First Eukaryotes and the Blueprint for Complex Life

Hematology & Blood Research Executive Overview

Archive

Tag: astrazeneca

AstraZeneca’s Phase III NSCLC Trial Setback: Re-Evaluating the PD-1 Bispecific Strategy in Advanced Oncology

Clinical Trials & Research

AstraZeneca’s Phase III NSCLC Trial Setback: Re-Evaluating the PD-1 Bispecific Strategy in Advanced Oncology

Executive Overview The landscape of immuno-oncology has long been defined by the pursuit of combination therapies and multi-targeted biologic agents...

23 Aug 2026